Tim Petersen co-founded Arboretum Ventures in 2002 and focused his investments on transformative opportunities that disrupt healthcare sectors starved of technology or business model innovation. His investments have spanned various healthcare sectors, including healthcare information technology, medical device, and research instrumentation companies.
Examples of Tim’s successful companies include Inogen (Nasdaq: INGN) which revolutionized the delivery of oxygen to COPD patients, and Pear Therapeutics (Nasdaq: PEAR), developer of the country’s first FDA-cleared “prescription digital therapeutic.”
He also led Arboretum’s investments into Advanced ICU Care, one of the nation’s largest acute care telemedicine solutions providers, and Accuri Cytometers, which upended the billion-dollar flow cytometry sector (sold to Becton Dickinson).
Other exited investments include SI-BONE (Nasdaq: SIBN) and behavioral health technology company HealthMedia (sold to Johnson & Johnson).
Tim holds a BA in Economics from Williams College, an MS in Economics from the University of Wisconsin-Madison, and an MBA from the Ross School of Business at the University of Michigan.